BioAlliance Pharma Announces That the Civil Action Filed by Eurofins in the United States is Rejected  
9/22/2009 1:49:17 PM

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) announces today that the American District Judge has granted the motion to dismiss of BioAlliance Pharma and one of its executive in response to the civil action filed by Eurofins. Eurofins filed an appeal.